Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles

• Status: Completed
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this prospective, randomized, double-blind, intraindividual split face study will be to compare onabotulinumtoxinA to incobotulinumtoxinA for the correction of facial wrinkles using a 1:1 dose ratio.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: YMD Eye and Face
• Treatments: abobotulinumtoxinA; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• males and females age 18 or older.

Exclusion Criteria:

• Previous treatment with a neuromodulator in the last 6 months

• previous brow lift

• currently pregnant or breastfeeding

• a history of neurological disease or deficit

• an active facial skin infection

• an allergy to neuromodulators